Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2025-12-30 @ 2:58 AM
Study NCT ID:
NCT04941768
Status:
COMPLETED
Last Update Posted:
2025-11-28
First Post:
2021-06-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)
Sponsor:
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-09
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-23
First Submit QC Date:
None
Study First Post Date:
2021-06-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-08-07
Results First Submit QC Date:
None
Results First Post Date:
2025-11-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-17
Last Update Post Date:
2025-11-28
Last Update Post Date Type:
ESTIMATED